Dr. Sleiman and Prof. Damha receive CFI award for their work on Nucleic Acids for Precision Medicine

Congratulations to D2R’s Associate Scientific Director, Hanadi Sleiman, and Professor Masad J. Damha on their recent award from the Canada Foundation for Innovation (CFI) for their groundbreaking work on Nucleic Acids for Precision Medicine.

Read the full article about the awarded grants here.